Validation of the French Version of the Stapesplasty Outcome Test 25 (SPOT-25)
QOLOTOSC
1 other identifier
observational
150
1 country
2
Brief Summary
Inclusion (J0):
- Audiometry (as part of the treatment, only for cases)
- Clinical evaluation (within the framework of care, only for cases)
- Passage of the French version of the SPOT-25 questionnaire Visit 1 (D0 + 3 ± 1 week): only for cases Second examination of the French version of the SPOT-25 questionnaire (re-test) either by telephone and e-mail, or during a consultation or hospitalization, if this occurs within a compatible time frame. Visit 2 (3-6 months postoperatively): only for operated patients Third examination of the French version of the SPOT-25 questionnaire either by telephone and e-mail, or during a consultation or hospitalization, if this occurs within a compatible time frame.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2021
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 26, 2021
CompletedFirst Posted
Study publicly available on registry
June 1, 2021
CompletedStudy Start
First participant enrolled
September 9, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 6, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 6, 2022
CompletedFebruary 14, 2023
February 1, 2023
7 months
May 26, 2021
February 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of the total score of cases and controls for the French version of the SPOT-25 questionnaire
The SPOT-25 questionnaire includes 25 items and can be divided into 4 subscores: hearing function (items 1-10), tinnitus (items 11-13), mental condition (items 14-19), and social restrictions (items 20-24). In addition, 1 item focuses on the general evaluation of the impact of otosclerosis on HRQOL (item 25). Each question needs to be rated on a six-point ordinal scale from 0 (i.e., no impact) to 5 (i.e., most severe impact), depending on the level of inconvenience or frequency of symptoms.
1 DAY
Study Arms (3)
case: patient with otosclerosis
Diagnosis of otosclerosis with indication for primary stapedial surgery by the combination of arguments
case: otosclerosis patient with surgery
otosclerosis patient with surgery
controle: Absence of known otological pathology
Absence of known otological pathology
Interventions
spot-25 questionnaire
Eligibility Criteria
patients with otosclerosis and person with a known Absence of otological pathology
You may qualify if:
- Patient aged\> 18 years
- Diagnosis of otosclerosis with indication for primary stapes surgery by the combination of the arguments:
- Clinical: normal eardrum and audiometry revealing conductive or mixed hearing loss with audiometric Rinne of\> 15 dB and absence of stapedial reflex.
- Radiological: otosclerotic foci on preoperative CT scan
- Non-opposition to participating in the study
- Good understanding of French
- Affiliate or beneficiary of a health insurance plan
- Person aged\> 18 years
- Absence of known otological pathology
- Without otological surgical history
- Non-opposition to participating in the study
- Good understanding of French
You may not qualify if:
- Comorbidity that may interfere with the interpretation of results
- History of stapes surgery
- Person benefiting from a legal protection measure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Fondation Adolphe de Rothschild
Paris, 75019, France
Amélie YAvchitz
Paris, Île-de-France Region, 75019, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 26, 2021
First Posted
June 1, 2021
Study Start
September 9, 2021
Primary Completion
April 6, 2022
Study Completion
April 6, 2022
Last Updated
February 14, 2023
Record last verified: 2023-02